TWD 70.7
(-3.42%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.99 Billion TWD | 91.77% |
2022 | 1.03 Billion TWD | 1.18% |
2021 | 1.02 Billion TWD | -6.5% |
2020 | 1.09 Billion TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.98 Billion TWD | -0.23% |
2024 Q2 | 2 Billion TWD | 1.05% |
2023 Q2 | 1.51 Billion TWD | 42.97% |
2023 FY | 1.99 Billion TWD | 91.77% |
2023 Q1 | 1.06 Billion TWD | 0.0% |
2023 Q4 | 1.99 Billion TWD | 1.88% |
2023 Q3 | 1.95 Billion TWD | 28.99% |
2022 Q4 | - TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | 4.135% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -69.558% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -64.192% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 79.818% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 83.008% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 81.567% |
Center Laboratories, Inc. | 27 Billion TWD | 92.619% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -204.715% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | 22.232% |
InnoPharmax Inc. | 524.19 Million TWD | -280.19% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | -26.349% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | -9.947% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | -7.064% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 34.382% |
UniPharma Co., Ltd. | 350.07 Million TWD | -469.292% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | 10.17% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -104.781% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -148.566% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -354.932% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -267.262% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | -42.367% |